164 related articles for article (PubMed ID: 33640184)
1. Low-Dose vs Regular-Dose Aspirin for Venous Thromboembolism Prophylaxis in Primary Total Joint Arthroplasty.
Uvodich ME; Siljander MP; Taunton MJ; Mabry TM; Perry KI; Abdel MP
J Arthroplasty; 2021 Jul; 36(7):2359-2363. PubMed ID: 33640184
[TBL] [Abstract][Full Text] [Related]
2. No Difference Between Low- and Regular-dose Aspirin for Venous Thromboembolism Prophylaxis After THA.
Faour M; Piuzzi NS; Brigati DP; Klika AK; Mont MA; Barsoum WK; Higuera CA
Clin Orthop Relat Res; 2019 Feb; 477(2):396-402. PubMed ID: 30624322
[TBL] [Abstract][Full Text] [Related]
3. Thirty day low-dose versus regular-dose aspirin for venous thromboembolism prophylaxis in primary total joint arthroplasty.
Duke AJ; Bowen S; Baig S; Cohen D; Komatsu DE; Nicholson J
J Orthop Surg (Hong Kong); 2023; 31(2):10225536231173329. PubMed ID: 37137821
[TBL] [Abstract][Full Text] [Related]
4. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
Arsoy D; Giori NJ; Woolson ST
Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
[TBL] [Abstract][Full Text] [Related]
5. Weight-Based Aspirin Dosing May Further Reduce the Incidence of Venous Thromboembolism Following Primary Total Joint Arthroplasty.
Halbur CR; Gulbrandsen TR; West CR; Brown TS; Noiseux NO
J Arthroplasty; 2021 Dec; 36(12):3986-3992.e1. PubMed ID: 34215460
[TBL] [Abstract][Full Text] [Related]
6. Low-Dose Aspirin Administered for Venous Thromboembolism Prophylaxis Reduces the Incidence of Heterotopic Ossification in Total Joint Arthroplasty.
Van Nest DS; Clarkson S; Chisari E; Sherman MB; Parvizi J
J Arthroplasty; 2021 May; 36(5):1543-1547. PubMed ID: 33485696
[TBL] [Abstract][Full Text] [Related]
7. Low-Dose Aspirin Is Safe and Effective for Venous Thromboembolism Prevention in Patients Undergoing Revision Total Hip Arthroplasty: A Retrospective Cohort Study.
Tang A; Zak S; Iorio R; Slover J; Bosco J; Schwarzkopf R
J Arthroplasty; 2020 Aug; 35(8):2182-2187. PubMed ID: 32334898
[TBL] [Abstract][Full Text] [Related]
8. Risk-Stratified Venous Thromboembolism Prophylaxis after Total Joint Arthroplasty: Low Molecular Weight Heparins and Sequential Aspirin vs Aggressive Chemoprophylaxis.
Peng HM; Chen X; Wang YO; Bian YY; Feng B; Wang W; Weng XS; Qian WW
Orthop Surg; 2021 Feb; 13(1):260-266. PubMed ID: 33448672
[TBL] [Abstract][Full Text] [Related]
9. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
[TBL] [Abstract][Full Text] [Related]
10. Aspirin Is Safe for Venous Thromboembolism Prophylaxis for Patients With a History of Gastrointestinal Issues.
Grosso MJ; Kozaily E; Parvizi J; Austin MS
J Arthroplasty; 2021 Jul; 36(7S):S332-S336. PubMed ID: 33610409
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Aspirin for Venous Thromboembolism Prophylaxis is Associated With Lower Rates of Periprosthetic Joint Infection After Total Joint Arthroplasty.
Najafi F; Kendal JK; Peterson NV; Ciesielka KA; Restrepo C; Parvizi J; Bernthal NM
J Arthroplasty; 2022 Dec; 37(12):2444-2448.e1. PubMed ID: 35843380
[TBL] [Abstract][Full Text] [Related]
12. Thirty Days of Aspirin for Venous Thromboembolism Prophylaxis Is Adequate Following Total Knee Arthroplasty, Regardless of the Dose Used.
Shohat N; Ludwick L; Goel R; Ledesma J; Streicher S; Parvizi J
J Arthroplasty; 2021 Sep; 36(9):3300-3304. PubMed ID: 34052098
[TBL] [Abstract][Full Text] [Related]
13. Aspirin Is as Effective as and Safer Than Warfarin for Patients at Higher Risk of Venous Thromboembolism Undergoing Total Joint Arthroplasty.
Huang RC; Parvizi J; Hozack WJ; Chen AF; Austin MS
J Arthroplasty; 2016 Sep; 31(9 Suppl):83-6. PubMed ID: 27094242
[TBL] [Abstract][Full Text] [Related]
14. Low-Dose Aspirin Is Effective Chemoprophylaxis Against Clinically Important Venous Thromboembolism Following Total Joint Arthroplasty: A Preliminary Analysis.
Parvizi J; Huang R; Restrepo C; Chen AF; Austin MS; Hozack WJ; Lonner JH
J Bone Joint Surg Am; 2017 Jan; 99(2):91-98. PubMed ID: 28099298
[TBL] [Abstract][Full Text] [Related]
15. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
16. Incidence and risk factors associated with venous thromboembolism following primary total hip arthroplasty in low-risk patients when using aspirin for prophylaxis.
Howard TA; Judd CS; Snowden GT; Lambert RJ; Clement ND
Hip Int; 2022 Sep; 32(5):562-567. PubMed ID: 33594900
[TBL] [Abstract][Full Text] [Related]
17. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
[TBL] [Abstract][Full Text] [Related]
18. Incidence of Symptomatic Venous Thromboembolism in Patients with Hemophilia Undergoing Hip and Knee Joint Replacement without Chemoprophylaxis: A Retrospective Study.
Peng HM; Wang LC; Zhai JL; Jiang C; Weng XS; Feng B; Gao N
Orthop Surg; 2019 Apr; 11(2):236-240. PubMed ID: 30932356
[TBL] [Abstract][Full Text] [Related]
19. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
20. Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trial.
Ren Y; Cao SL; Li Z; Luo T; Feng B; Weng XS
Chin Med J (Engl); 2021 Jan; 134(2):164-172. PubMed ID: 33410616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
